Ixazomib Treatment of IgA Multiple Myeloma With Hyperviscosity Syndrome
Open Access
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 20 (11) , e832-e835
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Evidence-based focused review of management of hyperviscosity syndromeBlood, 2012
- Acquired Dysfibrinogenemia Secondary to Multiple MyelomaActa Haematologica, 2008
- Cerebral Infarction in IgG Multiple Myeloma with HyperviscosityJournal of Korean Medical Science, 2005
- Hyperviscosity Syndrome in Plasma Cell DyscrasiasSeminars in Thrombosis and Hemostasis, 2003
- Review of 1027 Patients With Newly Diagnosed Multiple MyelomaMayo Clinic Proceedings, 2003
- Consider ‘Hyperviscosity Syndrome’ in Unexplained BreathlessnessActa Haematologica, 2000
- The Relationship between Serum Viscosity, Hypervolaemia and Clinical Manifestations Associated with Circulating ParaproteinBritish Journal of Haematology, 1978
- Hyperviscosity Syndrome in IgA Multiple MyelomaBritish Journal of Haematology, 1974
- Hyperviscosity syndrome with IgA myelomaThe American Journal of the Medical Sciences, 1972
- Aggregation phenomenon in an IgG multiple myeloma resulting in the hyperviscosity syndromeThe American Journal of Medicine, 1971